Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 10:28 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 577–600 of 1,943 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Context 2 Clear all

Conditions: Anaplastic (Malignant) Meningioma, Atypical Meningioma, Grade II Meningioma, Grade III Meningioma, Recurrent Meningioma, Supratentorial Meningioma
Interventions: Bevacizumab, Electric Field Therapy, NovoTTF-200A Device, Quality-of-Life Assessment; Biological · Procedure · Device
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2026
U.S. locations: 8
States / cities: Santa Monica, California • Miami, Florida • Atlanta, Georgia + 5 more

Conditions: Dementia
Interventions: Dementia Symptom Management at Home Program; Behavioral
Lead sponsor: New York University; Other
Eligibility: 65 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 2
States / cities: New York, New York

Conditions: Obesity
Interventions: Egg Breakfast (EB), Cereal Breakfast (CB), Weight Loss Counseling, Weight Loss Diet; Behavioral
Lead sponsor: Texas Tech University; Other
Eligibility: 18 Years to 44 Years · Female only
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Lubbock, Texas

Conditions: Obesity, Overweight, Weight Loss, Weight Loss Maintenance
Interventions: Weight loss maintenance intervention face-to-face, Weight loss maintenance intervention delivered via DVD; Behavioral
Lead sponsor: University of Hawaii; Other
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2015
U.S. locations: 8
States / cities: Honolulu, Hawaii • Kailua-Kona, Hawaii • Kaunakakai, Hawaii

Conditions: Obesity
Interventions: Calorie-counting, MyPlate; Behavioral
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 18 Years and older
Enrollment: 261 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2017
U.S. locations: 2
States / cities: Long Beach, California • Los Angeles, California

Conditions: Decreasing Destructive Behavior, Increasing Functional Communicative Behavior
Interventions: Traditional Schedule Thinning, PIA-Informed Schedule Thinning, PIA-Informed Schedule Thinning with Competing Stimuli; Behavioral
Lead sponsor: Rutgers, The State University of New Jersey; Other
Eligibility: 3 Years to 17 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2028
U.S. locations: 2
States / cities: New Brunswick, New Jersey • Somerset, New Jersey

Conditions: Stress Physiology, Stress Reaction, Substance Use Disorders, Methamphetamine-dependence, Stress, Emotional
Interventions: Standard social stress task, Stressful experience in the ED; Behavioral
Lead sponsor: University of Arkansas; Other
Eligibility: 21 Years to 55 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2026
U.S. locations: 1
States / cities: Little Rock, Arkansas

Conditions: Development Delay, Social Skills, Parents
Interventions: Parent Training, Video Modeling; Behavioral
Lead sponsor: University of Nevada, Las Vegas; Other
Eligibility: 3 Years and older
Enrollment: 14 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Las Vegas, Nevada

Conditions: Cigarette Smoking, Schizophrenia, Bipolar Disorder, Depressive Disorder, Major, Smoking Cessation
Interventions: Academic Detailing, Community Health Worker, Treatment as Usual (TAU); Other
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 1,165 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2021
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Pancreatic Cancer, Adenocarcinoma of the Pancreas, Squamous Cell Carcinoma of Pancreas, Adenosquamous Carcinoma of the Pancreas
Interventions: ZIMBERELIMAB, DOMVANALIMAB, APX005M, FOLFIRI; Drug
Lead sponsor: James Cleary, MD, PhD; Other
Eligibility: 18 Years and older
Enrollment: 46 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2032
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Breast Cancer, Invasive Breast Cancer
Interventions: Anastrozole, Letrozole, Exemestane, Tamoxifen; Drug
Lead sponsor: Medical College of Wisconsin; Other
Eligibility: 18 Years and older · Female only
Enrollment: 37 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2025
U.S. locations: 1
States / cities: Milwaukee, Wisconsin

Conditions: Older Adults, Physical Deconditioning
Interventions: Progressive Multi-Component (PMC), Enhanced Usual Care (EUC); Behavioral
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 65 Years to 100 Years
Enrollment: 353 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2022
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Substance Use, Substance Abuse, Suicide
Interventions: Thiwáhe Gluwáš'akapi, Woyute Waśte; Behavioral
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 10 Years to 85 Years
Enrollment: 552 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2025
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Small Cell Lung Cancer, Ovarian Cancer
Interventions: LCL161, Topotecan, Pegylated GCSF (PEG-GCSF); Drug
Lead sponsor: SCRI Development Innovations, LLC; Other
Eligibility: 18 Years and older
Enrollment: 34 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2021
U.S. locations: 3
States / cities: Sarasota, Florida • Oklahoma City, Oklahoma • Nashville, Tennessee

Conditions: Hip Pain Chronic
Interventions: iVR Group, Standard pain management regimen; Device · Drug
Lead sponsor: Cedars-Sinai Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Attention Deficit Hyperactivity Disorder
Interventions: I2-ART, Usual care; Behavioral · Other
Lead sponsor: Children's Hospital Medical Center, Cincinnati; Other
Eligibility: 18 Years and older
Enrollment: 108 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2026
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Hypertension, Family Relations
Interventions: Walk Together; Behavioral
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years to 75 Years
Enrollment: 62 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Attention-Deficit/Hyperactivity Disorder (ADHD)
Interventions: Music-Based Binaural Beats Stimulation, Music Listening Without Binaural Beats; Behavioral
Lead sponsor: California State University, San Bernardino; Other
Eligibility: 18 Years to 55 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: San Bernardino, California

Conditions: Spinal Cord Injury
Interventions: Electromagnetic Neuromodulation; Device
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 18 Years to 45 Years · Male only
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2027
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Attention Deficit Hyperactivity Disorder (ADHD)
Interventions: AR11, Placebo; Drug
Lead sponsor: Arbor Pharmaceuticals, Inc.; Industry
Eligibility: 6 Years to 12 Years
Enrollment: 97 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 7
States / cities: Bradenton, Florida • Maitland, Florida • South Miami, Florida + 3 more

Conditions: Pain, Solid Tumor
Interventions: medical chart review, questionnaire administration, survey administration; Other
Lead sponsor: Vanderbilt-Ingram Cancer Center; Other
Eligibility: 21 Years and older
Enrollment: 22 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2011
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Hiv, Adolescent Behavior, Family Relations, Sexual Orientation
Interventions: MySTYLE, Waitlist Control; Behavioral · Other
Lead sponsor: Rhode Island Hospital; Other
Eligibility: 14 Years to 20 Years
Enrollment: 72 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Jackson, Mississippi

Conditions: Smoking Cessation, Cigarette Smoking, Smoking (Tobacco) Addiction
Interventions: Nicotine Film; Drug
Lead sponsor: Milton S. Hershey Medical Center; Other
Eligibility: 18 Years to 55 Years
Enrollment: 45 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019
U.S. locations: 1
States / cities: Hershey, Pennsylvania

Conditions: Psychopathology
Interventions: Mom Power, Mom Power Informational Mailing; Behavioral
Lead sponsor: Tulane University; Other
Eligibility: 3 Years and older
Enrollment: 44 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: New Orleans, Louisiana

Search by objective public record fields.

Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma

The Dementia Symptom Management at Home Program

Breakfast Intake and Satiety Hormones

PILI at Work a 5-Year Controlled Intervention Trial: Testing DVD Versus Group Delivery of a Weight-Loss Maintenance Intervention in Native Hawaiian- Serving Worksites

Is MyPlate Approach to Helping Overweight Patients Lose Weight More Patient-centered?

Motivational Refinements for Facilitating Reinforcement Schedule Thinning

The Human Stress Response in a Simulated ED Setting

Home-Based Social Skills Intervention for Young Children With Developmental Delays

Integrated Smoking Cessation Treatment for Smokers With Serious Mental Illness

Switch Maintenance in Pancreatic

Neoadjuvant Endocrine Therapy in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Node-Negative Breast Cancer

Progressing Home Health Rehabilitation for Older Adults

Evaluation of Thiwáhe Gluwáš'Akapi Substance Use Prevention Program

LCL161 Plus Topotecan for Patients With Relapsed/Refractory Small Cell Lung Cancer and Select Gynecologic Malignancies

The Effectiveness of Immersive Virtual Reality as a Pain Control Modality After Hip Arthroscopy

Family Navigation to Improve ADHD Treatment Adherence for Minority Children

Walk Together: A Family-Based Intervention for Hypertension In African Americans

Binaural Beats Stimulation for Adults With Attention-Deficit/Hyperactivity Disorder

Improving Bladder Function in SCI by Neuromodulation

Crossover Study to Evaluate the Efficacy of AR11 in Pediatric Patients With ADHD in a Laboratory Classroom Setting

Pain Control in Hospice Patients With Cancer-Related Pain

MySTYLE: Online Family-based HIV Prevention for Non-heterosexual Black Adolescent Males in the South

Effects of Random Nicotine Delivery on Smoking Cessation

Virtual Mom Power With High-Adversity Mothers and Children (MPHAMC)